An Open Label Study Assessing REN Treatment in Headache Management in Temporomandibular Disorders | MicrobiomeTrials← Back to trialsNCT07639944
An Open Label Study Assessing REN Treatment in Headache Management in Temporomandibular Disorders
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-05-04Est. Completion: 2027-01-01
Enrollment target: 40 participants Locations- Proven Endpoints, Ridgeland, Mississippi, United States
- True North neurology, Commack, New York, United States
Other microbiome trials you might be interested in
Bruxism
Bruxism is a repetitive jaw-muscle activity that may lead to tooth wear, muscle pain, headaches, and functional limitati…
Bilecik, Turkey (Türkiye)Est. completion Dec 20, 2026
Temporomandibular Disorders (TMD)
Orofacial myofascial pain, most commonly represented by Temporomandibular Disorders (TMD) a significant public health, a…
Brest, FranceEst. completion Sep 1, 2028